155 related articles for article (PubMed ID: 19814747)
61. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases.
Artz AS; Somerfield MR; Feld JJ; Giusti AF; Kramer BS; Sabichi AL; Zon RT; Wong SL
J Clin Oncol; 2010 Jul; 28(19):3199-202. PubMed ID: 20516452
[TBL] [Abstract][Full Text] [Related]
62. Universal hepatitis B screening and management in patients with cancer who received immunosuppressive chemotherapy.
Thompson LA; Heath LJ; Freml H; Delate T
J Oncol Pharm Pract; 2020 Jul; 26(5):1141-1146. PubMed ID: 31789111
[TBL] [Abstract][Full Text] [Related]
63. A survey of clinical practices among oncologists regarding hepatitis B screening in patients with cancer.
Sundaram S; Patil P; Sengar M; Rathod R; Mehta S
Indian J Med Res; 2020 Jun; 151(6):604-608. PubMed ID: 32719235
[TBL] [Abstract][Full Text] [Related]
64. Clinical practice of hepatitis B screening in patients starting with chemotherapy: A survey among Dutch oncologists.
Leber K; Otten HJMMB; Brandjes DPM; Claassen MAA; Lauw FN
Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13495. PubMed ID: 34310787
[TBL] [Abstract][Full Text] [Related]
65. Hepatitis B screening before chemotherapy: a survey of practitioners' knowledge, beliefs, and screening practices.
Lee RS; Bell CM; Singh JM; Hicks LK
J Oncol Pract; 2012 Nov; 8(6):325-8, 1 p following 328. PubMed ID: 23598840
[TBL] [Abstract][Full Text] [Related]
66. Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy.
Paul S; Shuja A; Tam I; Kim EM; Kang S; Kapulsky L; Viveiros K; Lee H
Dig Dis Sci; 2016 Aug; 61(8):2236-2241. PubMed ID: 26993822
[TBL] [Abstract][Full Text] [Related]
67. [Screening practices for hepatitis B virus prior to viral reactivation risk therapies among different medical specialties. HEBRA Project].
García-Bengoechea M; Hernández-López C; Crespo J; Gea F;
Med Clin (Barc); 2012 Nov; 139(11):498-501. PubMed ID: 22982126
[No Abstract] [Full Text] [Related]
68. The compliance of doctors with viral hepatitis B screening and antiviral prophylaxis in cancer patients receiving cytotoxic chemotherapy using a hospital-based screening reminder system.
Sun WC; Hsu PI; Yu HC; Lin KH; Tsay FW; Wang HM; Tsai TJ; Chen WC; Lai KH; Cheng JS
PLoS One; 2015; 10(2):e0116978. PubMed ID: 25658926
[TBL] [Abstract][Full Text] [Related]
69. [Measures Against Hepatitis B Virus Reactivation Where Specialist Teams Collaborate].
Yamazaki M
Rinsho Byori; 2016 Sep; 64(9):1085-1090. PubMed ID: 30609464
[TBL] [Abstract][Full Text] [Related]
70. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology.
Sasadeusz J; Grigg A; Hughes PD; Lee Lim S; Lucas M; McColl G; McLachlan SA; Peters MG; Shackel N; Slavin M; Sundararajan V; Thompson A; Doyle J; Rickard J; De Cruz P; Gish RG; Visvanathan K
Clin Liver Dis; 2019 Aug; 23(3):487-492. PubMed ID: 31266622
[TBL] [Abstract][Full Text] [Related]
71. Cost-Effectiveness Analysis of Screening for Hepatitis B Virus Infection in Patients With Solid Tumors Before Initiating Chemotherapy.
Konijeti GG; Grandhe S; Tincopa M; Lane JA; Shrime MG; Singh S; Loomba R
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1600-1608.e4. PubMed ID: 31678602
[TBL] [Abstract][Full Text] [Related]
72. Late-onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologists.
Henson CC; Andreyev HJ; Symonds RP; Peel D; Swindell R; Davidson SE
Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):552-7. PubMed ID: 21550216
[TBL] [Abstract][Full Text] [Related]
73. Perception of hepatitis B virus infection reactivation-related issues among specialists managing hematologic malignancies: result of an Italian survey.
Marignani M; Marzano A; Begini P; Vitolo U; Luminari S; Levis A; Deli I; Gigante E; De Santis E; delle Fave G; Monarca B; Cox MC
Leuk Lymphoma; 2014 Nov; 55(11):2564-71. PubMed ID: 24471911
[TBL] [Abstract][Full Text] [Related]
74. Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy.
Hwang JP; Huang D; Vierling JM; Suarez-Almazor ME; Shih YT; Chavez-MacGregor M; Duan Z; Giordano SH; Hershman DL; Fisch MJ; Cantor SB
JCO Clin Cancer Inform; 2019 Mar; 3():1-12. PubMed ID: 30892921
[TBL] [Abstract][Full Text] [Related]
75. [Risk of HBV reactivation under chemotherapy and immunosuppressants].
Belle A; Bronowicki JP
Rev Prat; 2011 Jan; 61(1):52-4. PubMed ID: 21452543
[No Abstract] [Full Text] [Related]
76. Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center.
Hwang JP; Fisch MJ; Lok AS; Zhang H; Vierling JM; Suarez-Almazor ME
BMC Cancer; 2013 Nov; 13():534. PubMed ID: 24209764
[TBL] [Abstract][Full Text] [Related]
77. Hepatitis B outbreak associated with a hematology-oncology office practice in New Jersey, 2009.
Greeley RD; Semple S; Thompson ND; High P; Rudowski E; Handschur E; Xia GL; Ganova-Raeva L; Crawford J; Robertson C; Tan C; Montana B
Am J Infect Control; 2011 Oct; 39(8):663-670. PubMed ID: 21658812
[TBL] [Abstract][Full Text] [Related]
78. Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists.
Day FL; Link E; Thursky K; Rischin D
J Oncol Pract; 2011 May; 7(3):141-7. PubMed ID: 21886492
[TBL] [Abstract][Full Text] [Related]
79. Vaccination and screening for infections in patients with inflammatory bowel disease: a survey of Australian gastroenterologists.
Gupta A; Macrae FA; Gibson PR
Intern Med J; 2011 Jun; 41(6):462-7. PubMed ID: 19849740
[TBL] [Abstract][Full Text] [Related]
80. [Prevention and management of hepatitis B virus reactivation during anticancer or immunosuppressive therapy].
Oketani M; Tsubouchi H
Nihon Rinsho; 2011 May; 69 Suppl 4():520-5. PubMed ID: 22096973
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
